Characterization of physical properties of tissue factor-containing microvesicles and a comparison of ultracentrifuge-based recovery procedures

Journal of Extracellular Vesicles

Volumn 3, Issue 1, 2014, Pages

  Ettelaie, Camille ^a   Collier, Mary E W ^a,d   Maraveyas, Anthony ^b   Ettelaie, Rammile ^c  

^a UNIVERSITY OF HULL   (United Kingdom)

^b UNIVERSITY OF HULL   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Microvesicles; Relative density; Size distribution; Thrombin generation activity; Tissue factor; Ultracentrifugation

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7; GREEN FLUORESCENT PROTEIN; THROMBIN; THROMBOPLASTIN;

A375 CELL LINE; ARTICLE; ASPC 1 CELL; BLOOD SAMPLING; CELL COUNT; CELL DENSITY; CELL ISOLATION; CELL LINE; CELL SIZE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CULTURE MEDIUM; DENSITY GRADIENT CENTRIFUGATION; FLUORESCENCE ANALYSIS; FORCE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTERMETHOD COMPARISON; MDA MB 231 CELL; MEMBRANE MICROPARTICLE; PHYSICAL CHEMISTRY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RELATIVE DENSITY; ULTRACENTRIFUGATION;

EID: 84974639199     PISSN: None     EISSN: 20013078     Source Type: Journal    
DOI: 10.3402/jev.v3.23592     Document Type: Article

References (22)

1. Aleman MM, Gardiner C, Harrison P, Wolberg AS. Differential contributions of monocyte-and platelet-derived microparticles towards thrombin generation and fibrin formation and stability. J Thromb Haemost. 2011;9:2251-61.
2. Tesselaar ME, Romijn FP, Van Der Linden IK, Prins FA, Bertina RM, Osanto S. Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost. 2007;5:520-7.
3. Zwicker JI, Liebman HA, Neuberg D, Lacroix R, Bauer KA, Furie BC, et al. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res. 2009;15:6830-40.
4. Lee RD, Barcel DA, Williams JC, Wang JG, Boles JC, Manly DA, et al. Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity. Thromb Res. 2012;129:80-5.
5. Yuana Y, Bertina RM, Osanto S. Pre-analytical and analytical issues in the analysis of blood microparticles. Thromb Haemost. 2011;105:396-408.
6. Dean WL, Lee MJ, Cummins TD, Schultz DJ, Powell DW. Proteomic and functional characterisation of platelet microparticle size classes. Thromb Haemost. 2009;102:711-8.
7. Lechner D, Weltermann A. Circulating tissue factor-exposing microparticles. Thromb Res. 2008;122:S47-54.
8. Collier ME, Mah PM, Xiao Y, Maraveyas A, Ettelaie C. Microparticle-associated tissue factor is recycled by endothelial cells resulting in enhanced surface tissue factor activity. Thromb Haemost. 2013;110:966-76.
9. Tauro BJ, Greening DW, Mathias RA, Ji H, Mathivanan S, Scott AM, et al. Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods. 2012;56:293-304.
10. Kalra H, Adda CG, Liem M, Ang CS, Mechler A, Simpson RJ, et al. Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma. Proteomics. 2013;13:3354-64.
11. Collier ME, Ettelaie C. Regulation of the incorporation of tissue factor into microparticles by serine phosphorylation of the cytoplasmic domain of tissue factor. J Biol Chem. 2011; 286:11977-84.
12. Collier ME, Ettelaie C. Induction of endothelial cell proliferation by recombinant and microparticle-tissue factor involves beta1-integrin and extracellular signal regulated kinase activation. Arterioscler Thromb Vasc Biol. 2010;30:1810-7.
13. Ettelaie C, Su S, Li C, Collier ME. Tissue factor-containing microparticles released from mesangial cells in response to high glucose and AGE induce tube formation in microvascular cells. Microvasc Res. 2008;76:152-60.
14. Collier ME, Maraveyas A, Ettelaie C. Filamin-A is required for the incorporation of tissue factor into cell-derived microvesicles. Thromb Haemost. 2014;111:647-55.
15. Ettelaie C, Fountain D, Collier MEW, ElKeeb A, Xiao YP, Maraveyas A. Low molecular weight heparin downregulates tissue factor expression and activity by modulating growth factor receptor-mediated induction of nuclear factor-kB. Biochim Biophys Acta Mol Basis Dis. 2011;1812:1591-600.
16. Sturk-Maquelin KN, Nieuwland R, Romijn FP, Eijsman L, Hack CE, Sturk A. Pro-and non-coagulant forms of noncell-bound tissue factor in vivo. J Thromb Haemost. 2003; 1:1920-6.
17. van Doormaal F, Kleinjan A, Berckmans RJ, Mackman N, Manly D, Kamphuisen PW, et al. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study. Thromb Haemost. 2012; 108:160-5.
18. Davila M, Robles-Carrillo L, Unruh D, Huo Q, Gardiner C, Sargent IL, et al. Microparticle association and heterogeneity of tumor-derived tissue factor in plasma: is it important for coagulation activation? J Thromb Haemost. 2014;12:186-96.
19. Del Conde I, Shrimpton CN, Thiagarajan P, López JA. Tissuefactor-bearing microparticles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood. 2005; 106:1604-11.
20. Davizon P, Munday AD, López JA. Tissue factor, lipid rafts, and microparticles. Semin Thromb Hemost. 2010;36:857-64.
21. Sonnino S, Prinetti A. Membrane domains and the ''lipid raft'' concept. Curr Med Chem. 2013;20:4-21.
22. Brown DA, Rose JK. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell. 1992;68:533-44.